Triazoloquinazolinone derivatives as inhibitors of checkpoint kinases

Details for Australian Patent Application No. 2007243520 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Huang, Shaei Y.; Dudkin, Vadim Y.; Brnardic, Edward J.; Wang, Cheng; Fraley, Mark E.; Arrington, Kenneth L.

Agent Spruson & Ferguson

Pub. Number AU-B-2007243520

PCT Pub. Number WO2007/127138

Priority 60/794,694 25.04.06 US

Filing date 20 April 2007

Wipo publication date 8 November 2007

Acceptance publication date 19 July 2012

International Classifications

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/4196 - 1,2,4-Triazoles

A61K 31/4353 - ortho- or peri-condensed with heterocyclic ring systems

A61K 31/5025 - ortho- or peri-condensed with heterocyclic ring systems

A61P 35/00 Antineoplastic agents

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

6 November 2008 PCT application entered the National Phase

  PCT publication WO2007/127138 Priority application(s): WO2007/127138

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

19 July 2012 Application Accepted

  Published as AU-B-2007243520

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007243536-Biofuel composition and method of producing a biofuel

2007243519-Disubstituted aniline compounds